Human Papillomavirus (HPV) And Cytomegalovirus (CMV) Therapeutics Market
- 2026 年市場規模
- USD 4,783.60 Mn
- 2033 年預估規模
- USD 7,187.5 Mn
- 年複合成長率 CAGR
- 6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Human Papillomavirus (HPV) And Cytomegalovirus (CMV) Therapeutics Market, By Drug Type (HPV Therapeutics (Immunomodulatory Agents (Interleukins, Cytokines, Chemokine, and Others)), Keratolytic Agents (TCA and Bichloracetic Acid), Anti-neoplastic Agents, Sinecatechins, and CMV Therapeutics (Ganciclovir/ Valaganciclovir, Foscarnet, and Cidifovir)), By Application (HPV Therapeutics Application (Genital warts, Cervical cancer, Epidermodysplasia Verrucifdormis, and Others) and CMV Therapeutics Application (CMV Retinitis, Pneumonia, Gastrointestinal ulcers, Encephalitis, and Others)), By Distribution Chanel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Cytomegalovirus (CMV) infections spread through body fluids such as saliva, semen, breast milk, and urine. Signs and symptoms of the infections include, fatigue, fever, diarrhea, pneumonia, and hepatitis, shortness of breath, gastrointestinal ulceration, and bleeding.
Although no treatment for the infection caused by human papillomavirus (HPV) is available, symptoms can be treated. Most sexually active men and women suffer from HPV infections. The infections spread through oral, vaginal or anal sex. HPV can also be transmitted during birth to infant and can lead to genital or respiratory infections.
Market Dynamics
Increasing collaboration activities of major players is expected to propel growth of the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market. For instance, in November 2018, GeoVax Labs Inc. announced collaboration with Virometix. The collaboration focuses on development of therapeutic vaccines for HPV infections. This collaboration will include preclinical animal testing of GeoVax’s MVA-Vectored HPV vaccines candidates in combination with Virometix synthetic HPV vaccines candidates.
Moreover, increasing regulatory approvals for novel therapies is expected to boost the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market growth. For instance, in November 2017, Merck received the U.S. Food and Drug Administration approval for its Prevymis (letermovir) tablets and intravenous (IV) injection for prophylaxis of CMV infections and CMV seropositive recipients.
Key features of the study
• This report provides in-depth analysis of the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market size (US$ Mn), and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include, , Allergan, Bausch Health, GlaxoSmithKline, Lee’s Pharmaceutical Holdings, Merck Sharp & Dohme, Fougera Pharmaceuticals, Clinigen Group plc., Perrigo Company plc., Roche Holding AG, Biotest AG, and Fresenius Kabi
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
• By Drug Type
o HPV Therapeutics
Immunomodulatory Agents
o Interleukins
o Cytokines
o Chemokine
o Others
Keratolytic Agents
o TCA
o Bichloracetic Acid
Anti-neoplastic Agents
Sinecatechins
o CMV Therapeutics
Ganciclovir/ Valaganciclovir
Foscarnet
Cidifovir
• By Application
o HPV Therapeutics Application
Genital warts
Cervical cancer
Epidermodysplasia Verrucifdormis
Others
o CMV Therapeutics Application
CMV Retinitis
Pneumonia
Gastrointestinal ulcers
Encephalitis
Others
• By Distribution Chanel
o Hospitals Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Human Papillomavirus (HPV) And Cytomegalovirus (CMV) Therapeutics Market Companies
o Allergan
o Bausch Health
o GlaxoSmithKline
o Lee’s Pharmaceutical Holdings
o Merck Sharp & Dohme
o Fougera Pharmaceuticals
o Clinigen Group plc
o Perrigo Company plc
o Roche Holding AG
o Biotest AG
o Fresenius Kabi
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Epidemiology
o Technology Advancements
o Patent Analysis
o Adherence Rate
o Product Switch (U.S.)
o Historical Overview
o Merger and Acquisition
o Regulatory and Reimbursement Scenario
o PORTER’S Five Forces
o PEST Analysis
4. Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market, By Drug Type, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o HPV Therapeutics
Immunomodulatory Agents
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Interleukins
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Cytokines
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Chemokine
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Keratolytic Agents
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
TCA
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Bichloracetic Acid
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Anti-neoplastic Agents
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Sinecatechins
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o CMV Therapeutics
Ganciclovir/ Valaganciclovir
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Foscarnet
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Cidifovir
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
5. Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market, By Application, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o HPV Therapeutics Application
Genital warts
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Cervical cancer
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Epidermodysplasia Verrucifdormis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o CMV Therapeutics Application
CMV Retinitis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Pneumonia
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Gastrointestinal ulcers
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Encephalitis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
6. Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market, By Distribution Chanel, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Hospitals Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
7. Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Market, By Region, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, By Region, 2026 – 2033
Regional Trends
o North America
Market Size and Forecast, By Drug Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Drug Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o UK
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Drug Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Market Size and Forecast, By Drug Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
Market Size and Forecast, By Drug Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country/Region, 2026 – 2033, (USD Mn)
o North Africa
o Central Africa
o South Africa
o Middle East
Market Size and Forecast, By Drug Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
GlaxoSmithKline
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
ALLERGAN
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Bausch Health
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Lee’s Pharmaceuticals Holdings
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Merck Sharp & Dohme
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Fougera Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Clinigen Group plc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Perrigo Company plc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Roche Holdings AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Fresenius Kabi
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們